trending Market Intelligence /marketintelligence/en/news-insights/trending/xGdiyWojFYd_IEd4_TcRAA2 content esgSubNav
In This List

Cadila granted US FDA approval to market antidepressant

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Cadila granted US FDA approval to market antidepressant

The U.S. Food and Drug Administration granted Cadila Healthcare Ltd. approval to market a generic version of an antidepressant drug.

The Indian pharmaceutical company will market mirtazapine in three doses, which will be produced at its manufacturing facility in Baddi, India.